tiprankstipranks
Trending News
More News >
Novavax (NVAX)
NASDAQ:NVAX
US Market

Novavax (NVAX) Financial Statements

Compare
10,111 Followers

Novavax Financial Overview

Novavax's market cap is currently $1.19B. The company's EPS TTM is $-1.25; its P/E ratio is 4.15; Novavax is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 682.16M$ 556.38M$ 1.60B$ 197.58M$ 22.39M
Gross Profit$ 479.42M$ 212.61M$ 696.31M$ 197.58M$ 22.39M
Operating Income$ -248.93M$ -566.51M$ -644.74M$ -1.69B$ -416.72M
EBITDA$ -108.04M$ -487.39M$ -604.71M$ -1.68B$ -398.23M
Net Income$ -187.50M$ -545.06M$ -657.94M$ -1.74B$ -418.26M
Balance Sheet
Cash & Short-Term Investments$ 923.12M$ 568.50M$ 1.34B$ 1.52B$ 711.05M
Total Assets$ 1.56B$ 1.80B$ 2.26B$ 2.58B$ 1.58B
Total Debt$ 230.42M$ 229.08M$ 549.78M$ 453.99M$ 467.98M
Net Debt$ -299.81M$ -339.42M$ -787.10M$ -1.06B$ -85.42M
Total Liabilities$ 2.18B$ 2.51B$ 2.89B$ 2.93B$ 955.27M
Stockholders' Equity$ -623.84M$ -716.93M$ -634.08M$ -351.67M$ 627.21M
Cash Flow
Free Cash Flow$ -100.32M$ -772.77M$ -508.92M$ 265.46M$ -97.16M
Operating Cash Flow$ -87.26M$ -713.97M$ -415.94M$ 322.95M$ -42.54M
Investing Cash Flow$ -204.04M$ -58.81M$ -92.98M$ 100.15M$ -377.78M
Financing Cash Flow$ 260.58M$ 4.47M$ 324.99M$ 461.71M$ 984.76M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS